Tuberculosis (TB), the world’s deadliest infectious disease, is no longer a relic of the past. Cases are increasing in the United States, despite being both preventable and curable. Recent outbreaks, including one at Archbishop Riordan High School in San Francisco, highlight how this disease – historically associated with poverty – is re-emerging even in affluent areas.
A Disease of the Past, Present, and Future
For centuries, TB was a global scourge. In the 19th century, it killed one in seven people in the US and Europe. While advancements in sanitation, nutrition, and antibiotics dramatically reduced its prevalence, the disease has not been eradicated. Today, TB remains the leading cause of death from an infectious disease globally, infecting roughly 10 million people and killing 1.5 million annually.
The re-emergence of TB in developed countries isn’t accidental. Decades of underfunding public health infrastructure, combined with disruptions caused by the COVID-19 pandemic, have created vulnerabilities. Delays in diagnosis, medication shortages, and the growing challenge of latent infections turning active contribute to the problem.
The Hidden Threat: Latent Infections
The majority of the world’s population – approximately 25% – carries latent TB bacteria. These individuals are not contagious, but their infections can activate if their immune systems weaken. This is why outbreaks often appear unexpectedly in seemingly low-risk settings, like schools.
The Archbishop Riordan High School case demonstrates this. As of February 24, four students had active TB, with three more suspected. Over 200 tested positive for latent infection. The school’s policy, which allowed infected but non-contagious students on campus without mandatory treatment, exemplifies a broader challenge: how to balance public health with individual liberties.
Why It Matters Now
TB is insidious. Symptoms like chronic coughs can be misdiagnosed for months, allowing the disease to spread. Unlike highly contagious illnesses like measles, TB doesn’t immediately trigger panic, making it harder to control. Left untreated, one active case can infect 15 others per year.
The economic costs are substantial. Treating a single case of drug-resistant TB in the US can exceed $150,000. Continued underfunding of global health programs, like USAID, could lead to millions more deaths worldwide, with inevitable spillover effects at home.
What Needs to Change
Stopping TB requires sustained investment in research, prevention, and treatment. New diagnostics, vaccines, and medications are vital. But just as important is restoring and strengthening public health infrastructure. This means ensuring access to affordable testing, treatment, and education, particularly for vulnerable populations – including the homeless, incarcerated, and those with weakened immune systems.
The theme of this year’s World Tuberculosis Day, “Yes! We Can End TB!”, is ambitious but not impossible. Preventing the disease’s spread demands vigilance, funding, and a recognition that global health threats are local threats. Ignoring this reality will only ensure that TB continues its silent resurgence.
In conclusion, tuberculosis is not merely a historical disease; it’s a growing public health crisis that demands immediate attention. By investing in research, strengthening infrastructure, and prioritizing prevention, we can stop this deadly pathogen from gaining ground in the United States and beyond.
